Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:

Ø  an aromatase inhibitor as initial endocrine based therapy in postmenopausal women

fulvestrant in women with disease progression following endocrine therapy.

Website Prescribing Information Order Now

• Fllow Us

  • Facebook
  • Twitter
  • Linkedin
  • Youtube